NucleicNet software outperforms other algorithmic models of its kind and provides additional biological insights that could aid in drug design and development
A comprehensive RNA and DNA sequencing platform benefits late-stage and drug-resistant multiple myeloma patients by determining which drugs would work best for them
BD AbSeq is an assay that uses an oligo-conjugated antibody panel for protein cell-surface identification that can be added to RNA-seq single-cell experiments